Filing metadata

Accession number
0001104659-22-109998
Form type
Form 3
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Oct 19, 2022
Reporting period
Oct 17, 2022
Description
Initial ownership

Explore SEC Filings Hub